RxDoctor Payments DataLook up a doctor →

Joshua Greene, MD

Otolaryngology · Anderson, INNPI 1699034181

Payments from drug & device makers

$1,139,973in general payments, 2019–2025

Across 1,263 payments — averaging $902.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$805K
  • Smith+Nephew$316K
  • Spirair, Inc.$10K
  • GSK$8K
  • Biotissue Holdings Inc.$221
  • Olympus America Inc.$136
  • plus $589 from 11 others
$30,860in research payments, 2019–2025

Across 2 payments — averaging $15,430 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Neurent Medical Limited$31K

What the payments were for

  • Consulting fees$670,88670%
  • Speaking & faculty fees$135,81314%
  • Travel & lodging$123,95613%
  • Food & beverage$24,4013%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,139,973 in reported general payments places this provider in the 95th percentile of 193 otolaryngology providers in Indiana.

See all otolaryngology providers in Indiana

Medicare billing

Part B allowed, 2024
$126,992
Medicare patients
278
Services billed
890

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide71$2,352
Azelastine Hcl84$1,916
Omeprazole46$450
Montelukast Sodium62$415
ErythromycinErythromycin Base29$307
Mometasone Furoate12$183
Fluticasone Propionate17$153
Cephalexin21$140
Ciprofloxacin Hcl13$66

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Anderson

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →